Pearce IP appoints biotech/pharma IP leader Jacinta Flattery-O’Brien as Special Counsel

by | May 27, 2020

Boutique specialist firm Pearce IP is delighted to announce the appointment of biotech/pharma IP leader Jacinta Flattery-O’Brien PhD as Special Counsel.

A highly regarded patent attorney with a PhD in molecular biology and more than 20 years’ experience in the biotech, pharma and biopharma industries, Jacinta is recognised as an industry leader in patent strategies and patenting.

Jacinta is the former Team Leader of the life sciences team of Shelston IP, where she was Principal and Partner for over 14 years.

Flattery-O’Brien says:

“Pearce IP is well known for excellence in patent and legal services. I am thrilled to join this exceptional team of patent attorneys and lawyers and look forward to re-connecting with colleagues and clients.”

Pearce IP’s Principal Naomi Pearce says:

Jacinta’s patent capabilities, experience, and industry knowledge are second to none.  We’re really pleased to welcome Jacinta to Pearce IP.”

Flattery-O’Brien‘s arrival follows the recent addition of former Shelston IP leaders Grant Shoebridge PhD in April 2020, and Jennifer Enmon PhD in September 2019.

Please join us in congratulating Jacinta on her new appointment.

Naomi Pearce

Naomi Pearce

Principal Lawyer, Patent Attorney, Trade Mark Attorney

Naomi is listed in IAM Patent 1000 as one of Australia's leading patent litigators, and in IAM Strategy 300: The World's Leading IP Strategists. Underpinning Naomi’s legal work is a deep understanding of the pharma/biopharma industries, resulting from first hand experience and knowledge as VP of IP in-house at global pharma giants, and Partner of a top-tier international law firm.

Get our Pearce IP Blogs & BioBlast® sent directly to your inbox

Subscribe to our Pearce IP Blogs and BioBlast® to recieve our updates via email.

Our Latest News